Regional
Region One Metropolitan Ambulance Council (MAC)
The current listed document is more than 24 months old and may be outdated.
Drugs and doses39
A–C Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Buprenorphine, Calcium Chloride, Calcium Gluconate, Cefepime9
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 6–12 mg | IV/IO | not captured | standing | page 224 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 224 |
| Wide-complex tachycardia | peds | 0.1 mg/kg | IV | not captured | standing | page 224 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 5 mg | NEB | not captured | standing | page 225 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 225 |
| Other | adult | 5 mg | NEB | not captured | standing | page 225 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Post-ROSC care | adult | 150 mg | IV/IO | not captured | standing | page 226 |
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 226 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | page 226 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 226 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 226 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 160–325 mg | PO | not captured | standing | page 228 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 229 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 229 |
| Organophosphate poisoning | adult | 2 mg | IV/IO | not captured | standing | page 229 |
| Organophosphate poisoning | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 229 |
| RSI induction | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 229 |
Buprenorphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 8–16 mg | PO | not captured | standing | page 230 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 500–1000 mg | IV/IO | not captured | standing | page 231 |
| Cardiac arrest | adult | 1 g | IV/IO | not captured | standing | page 231 |
| Cardiac arrest | peds | 20 mg/kg | IV/IO | not captured | standing | page 231 |
| Crush injury | adult | 1 g | IV/IO | not captured | standing | page 231 |
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | page 231 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 4 mL | NEB | not captured | standing | page 197 |
| Other | peds | 4 mL | NEB | not captured | standing | page 197 |
Cefepime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Sepsis | adult | 2 g | IV | not captured | standing | page 61 |
| Sepsis | peds | 50 mg/kg | IV | not captured | standing | page 61 |
D–F Dexamethasone, Dextrose, Diazepam, Diltiazem, Diphenhydramine, Droperidol, Epinephrine, Etomidate, Fentanyl9
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 16 mg | IV/IO/IM/PO | not captured | standing | page 58 |
| Anaphylaxis | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 58 |
| Asthma / bronchospasm | adult | 16 mg | IV/IO/IM/PO | not captured | standing | page 59 |
| Asthma / bronchospasm | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 59 |
| Croup | adult | 16 mg | IV/IO/IM/PO | not captured | standing | page 163 |
| Croup | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 163 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | peds | 1 mL/kg | IV/IO | not captured | standing | page 162 |
| Hypoglycemia | adult | 12.5 g | IV/IO | not captured | standing | page 64 |
| Hypoglycemia | peds | 2 mL/kg | IV/IO | not captured | standing | page 64 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5 mg | IV/IM | not captured | standing | page 67 |
| Hyperactive delirium | adult | 4 mg | IV/IM | not captured | standing | page 68 |
| Post-intubation sedation | adult | 5 mg | IV/IM | not captured | standing | page 56 |
| Seizure | adult | 5 mg | IV/IO/IM | not captured | standing | page 66 |
| Seizure | peds | 0.2 mg/kg | IV/IO/IM | not captured | standing | page 66 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 10 mg | IV/IO | not captured | standing | page 109 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 50 mg | IV/IM | not captured | standing | page 58 |
| Allergic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 58 |
| Other | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 63 |
| Other | peds | 1–2 mg/kg | IV/IO/IM | not captured | standing | page 63 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 5 mg | IM | not captured | standing | page 68 |
| Nausea / vomiting | adult | 1.25 mg | IV | not captured | standing | page 69 |
| RSI induction | adult | 1.25 mg | IV | not captured | standing | page 55 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | page 58 |
| Anaphylaxis | adult | 1 mL | IV/IO | not captured | standing | page 58 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | page 58 |
| Asthma / bronchospasm | adult | 0.3 mg | IM | not captured | standing | page 59 |
| Asthma / bronchospasm | peds | 0.15 mg | IM | not captured | standing | page 59 |
| Bradycardia | adult | 1 mL | IV/IO | not captured | standing | page 108 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 108 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 106 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 73 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 106 |
| CHF / pulmonary edema | adult | 2–20 mcg | IV/IO | not captured | standing | page 111 |
| Croup | peds | 3 mg | NEB | not captured | standing | page 163 |
| Neonatal resuscitation | peds | 0.01–0.03 mg/kg | IV/IO | not captured | standing | page 175 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 243 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 25–50 mcg | IV/IO/IM/IN | not captured | standing | page 110 |
| Nausea / vomiting | adult | 25–50 mcg | IV/IO/IM/IN | not captured | standing | page 69 |
| Mild to moderate pain | adult | 1 mcg/kg | IV/IM/IN | not captured | standing | page 69 |
| Mild to moderate pain | adult | 25–50 mcg | IV/IM | not captured | standing | page 135 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IM/IN | not captured | standing | page 69 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IM | not captured | standing | page 135 |
| Post-intubation sedation | adult | 25–50 mcg | IV/IO | not captured | standing | page 56 |
G–L Hydroxycobalamin, Ipratropium, Ketamine, Ketorolac, Lidocaine, Lorazepam6
Hydroxycobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | page 195 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | page 195 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | page 59 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | page 59 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 4 mg/kg | IM | not captured | standing | page 68 |
| Bradycardia | adult | 1 mg/kg | IV/IO/IM | not captured | standing | page 108 |
| Hyperactive delirium | adult | 4 mg/kg | IM | not captured | standing | page 68 |
| Mild to moderate pain | peds | 0.2 mg/kg | IV/IO | not captured | standing | page 135 |
| Post-intubation sedation | adult | 1 mg/kg | IV/IO/IM | not captured | standing | page 56 |
| Narrow-complex tachycardia | adult | 1 mg/kg | IV/IO/IM | not captured | standing | page 109 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 15 mg | IV/IM | not captured | standing | page 43 |
| Severe pain | peds | 0.5 mg/kg | IV/IM | not captured | standing | page 43 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mg/kg | IV | not captured | standing | page 251 |
| Other | adult | 20–40 mg | IO | not captured | standing | page 251 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | IV/IM | not captured | standing | page 67 |
| Hyperactive delirium | adult | 4 mg | IV/IM | not captured | standing | page 68 |
| Post-intubation sedation | adult | 2–4 mg | IV/IM | not captured | standing | page 56 |
| Seizure | adult | 2 mg | IV/IO/IM | not captured | standing | page 56 |
| Seizure | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 56 |
M–O Magnesium Sulfate, Methylprednisolone, Metoprolol, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron, Oral Glucose10
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV/IO | not captured | standing | page 45 |
| Asthma / bronchospasm | peds | 50 mg/kg | IV/IO | not captured | standing | page 45 |
| Eclampsia / pre-eclampsia | adult | 10 g | IM | not captured | standing | page 253 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV/IO | not captured | standing | page 45 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | page 45 |
| VF / pulseless VT | peds | 50 mg/kg | IV/IO | not captured | standing | page 45 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 125 mg | IV/IO/IM | not captured | standing | page 41 |
| Anaphylaxis | adult | 125 mg | IV/IO/IM | not captured | standing | page 58 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 58 |
| Asthma / bronchospasm | adult | 125 mg | IV/IO/IM | not captured | standing | page 59 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 59 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 5 mg | IV | not captured | standing | page 109 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–5 mg | IV/IM/IN | not captured | standing | page 67 |
| Bradycardia | adult | 2.5–5 mg | IV/IO/IN | not captured | standing | page 108 |
| CHF / pulmonary edema | adult | 2.5 mg | IV/IO/IM | not captured | standing | page 111 |
| Hyperactive delirium | adult | 5 mg | IM | not captured | standing | page 68 |
| Post-intubation sedation | adult | 5 mg | IV/IO/IM | not captured | standing | page 56 |
| Seizure | adult | 10 mg | IM | not captured | standing | page 66 |
| Seizure | adult | 2.5 mg | IV/IO/IM | not captured | standing | page 66 |
| Seizure | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 66 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | page 66 |
| Narrow-complex tachycardia | adult | 2.5–5 mg | IV/IO/IN | not captured | standing | page 109 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2–4 mg | IV/IO/IM | not captured | standing | page 259 |
| Mild to moderate pain | adult | 2–4 mg | IV/IO/IM | not captured | standing | page 135 |
| Mild to moderate pain | peds | 0.05 mg/kg | IV/IO | not captured | standing | page 174 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.5–2 mg | IV/IO/IM | not captured | standing | page 63 |
| Opioid overdose | adult | 2–4 mg | IN | not captured | standing | page 63 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 63 |
| Opioid overdose | peds | 0.1 mg/kg | IN | not captured | standing | page 63 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 110 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 111 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 2–12 mcg | IV/IO | not captured | standing | page 111 |
| Hypotension / shock | adult | 2–12 mcg | IV/IO | not captured | standing | page 60 |
| Post-ROSC care | adult | 2–12 mcg | IV/IO | not captured | standing | page 107 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 4 mg | IV | not captured | standing | page 110 |
| Nausea / vomiting | adult | 4 mg | IV/IO/PO | not captured | standing | page 69 |
| Nausea / vomiting | peds | 2 mg | IV/IO/PO | not captured | standing | page 69 |
| Mild to moderate pain | adult | 4 mg | IV/IO/IM | not captured | standing | page 135 |
| RSI induction | adult | 4 mg | IV/IO | not captured | standing | page 55 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | page 64 |
| Hypoglycemia | peds | 15 g | PO | not captured | standing | page 64 |
P–R Pralidoxime, Rocuronium2
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Organophosphate poisoning | adult | 1 g | IV/IO | not captured | standing | page 196 |
| Organophosphate poisoning | peds | 15 mg/kg | IV/IO | not captured | standing | page 196 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1.2 mg/kg | IV/IO | not captured | standing | page 204 |
S–Z Sodium Bicarbonate, Succinylcholine, Tranexamic Acid3
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 100 mEq | IV/IO | not captured | standing | page 68 |
| Crush injury | adult | 50 mEq | IV/IO | not captured | standing | page 139 |
| Hyperkalemia | adult | 100 mEq | IV/IO | not captured | standing | page 139 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 63 |
| Other | adult | 2.5 mL | NEB | not captured | standing | page 198 |
| Tricyclic overdose | adult | 1–2 mEq/kg | IV/IO | not captured | standing | page 63 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | page 204 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | page 76 |
Cite this
Region One Metropolitan Ambulance Council (MAC), United States EMS Protocol Census. 141 dose entries, effective 2024-03-01.
https://protoquiz.com/census/agencies/region-one-metropolitan-ambulance-council-mac/
The census is free and not for sale. Only public agencies are named.